Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia
JM Izquierdo‐Palomares… - Cochrane Database …, 2016 - cochranelibrary.com
Background Elevated levels of total cholesterol and low‐density lipoprotein play an
important role in the development of atheromas and, therefore, in cardiovascular diseases …
important role in the development of atheromas and, therefore, in cardiovascular diseases …
Safety profile of atorvastatin 80 mg: a meta-analysis of 17 randomized controlled trials in 21,910 participants
H Li, C Wang, S Zhang, S Sun, R Li, M Zou, G Cheng - Drug safety, 2016 - Springer
Introduction Atorvastatin 80 mg/day has significant benefits for the primary and secondary
prevention of cardiovascular and cerebrovascular disease. To our knowledge, no meta …
prevention of cardiovascular and cerebrovascular disease. To our knowledge, no meta …
Improvement of the survival and therapeutic effects of implanted mesenchymal stem cells in a rat model of coronary microembolization by rosuvastatin treatment.
FY Fu, BY Chen, LL Chen, FL Zhang… - European Review for …, 2016 - search.ebscohost.com
OBJECTIVE: As the impairment of myocardial micro-environments with local inflammatory
reactions due to coronary micro-embolization (CME) reduces the survival of transplanted …
reactions due to coronary micro-embolization (CME) reduces the survival of transplanted …
[HTML][HTML] Эффективность и безопасность статинов в кардиохирургии
ОЛ Барбараш, ОВ Малева, ОА Трубникова - Доктор. ру, 2016 - cyberleninka.ru
Цель обзора: отразить последние результаты клинических наблюдений эффектов
статинов в периоперационном периоде коронарного шунтирования (КШ). Основные …
статинов в периоперационном периоде коронарного шунтирования (КШ). Основные …
[PDF][PDF] 1. Department of Molecular & Clinical Pharmacology, University of Liverpool 2. Department of Biostatistics, University of Liverpool 3. Liverpool Heart and Chest …
RM Turner, P Yin, PDA Hanson, BSR FitzGerald… - 2016 - cyberleninka.org
Investigating the prevalence, predictors and prognosis of suboptimal statin use early after a
non-ST elevation acute coronary sy Page 1 Accepted Manuscript Investigating the prevalence …
non-ST elevation acute coronary sy Page 1 Accepted Manuscript Investigating the prevalence …
ВЫСОКОИНТЕНСИВНАЯ ТЕРАПИЯ АТОРВАСТАТИНОМ У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
ГВ Кузнецова, АВ Потехина, ТИ Арефьева… - Кардиологический …, 2016 - elibrary.ru
В настоящем обзоре рассматривается опыт применения высокоинтенсивной терапии
аторвастатином у пациентов с ишемической болезнью сердца (ИБС) как при …
аторвастатином у пациентов с ишемической болезнью сердца (ИБС) как при …
Addressing the Missing Heritability of Coronary Artery Disease
KLS Hartmann - 2016 - rave.ohiolink.edu
There is often a strong genetic component to human health and disease–reflected in the
importance of an individual's family history in clinical practice. This is true for coronary artery …
importance of an individual's family history in clinical practice. This is true for coronary artery …